Stocks and Investing
Stocks and Investing
Mon, July 15, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, July 12, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Michael Ulz Maintained (ALNY) at Hold with Increased Target to $255 on, Jul 12th, 2024
Michael Ulz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Increased Target from $250 to $255 on, Jul 12th, 2024.
Michael has made no other calls on ALNY in the last 4 months.
There are 15 other peers that have a rating on ALNY. Out of the 15 peers that are also analyzing ALNY, 3 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jessica Fye of "JP Morgan" Maintained at Hold with Increased Target to $248 on, Wednesday, July 3rd, 2024
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $150 on, Monday, July 1st, 2024
- Tiago Fauth of "Wells Fargo" Maintained at Hold with Increased Target to $207 on, Tuesday, June 25th, 2024
These are the ratings of the 12 analyists that currently disagree with Michael
- Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $357 on, Monday, July 8th, 2024
- Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $288 on, Friday, June 28th, 2024
- Luca Issi of "RBC Capital" Maintained at Buy with Increased Target to $265 on, Thursday, June 27th, 2024
- Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $295 on, Thursday, June 27th, 2024
- Ritu Baral of "TD Cowen" Maintained at Strong Buy with Increased Target to $282 on, Tuesday, June 25th, 2024
- Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $260 on, Tuesday, June 25th, 2024
- David Lebovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $291 on, Tuesday, June 25th, 2024
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $291 on, Tuesday, June 25th, 2024
- Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $275 on, Monday, June 24th, 2024
- Kostas Biliouris of "BMO Capital" Maintained at Buy and Held Target at $234 on, Monday, June 24th, 2024
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $400 on, Monday, June 24th, 2024
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $225 on, Friday, May 3rd, 2024
Contributing Sources